— Know what they know.
Not Investment Advice

SRDX NASDAQ

Surmodics, Inc.
1W: +0.0% 1M: +59.6% 3M: +26.3% 1Y: +8.7% 3Y: +18.0% 5Y: +15.5%
$42.98
Last traded 2025-11-28 — delisted
NASDAQ · Healthcare · Medical - Devices · $614.5M mcap · 13M float · 3.34% daily turnover · Short 43% of daily vol

Balance Sheet Trends

Total Assets
$179M -3.9% ▼
5Y CAGR: +2.2%
Total Liabilities
$60M -9.4% ▼
5Y CAGR: +9.8%
Shareholders Equity
$119M -0.8% ▼
5Y CAGR: -0.6%
Cash & Investments
$40M -11.6% ▼
5Y CAGR: -6.2%
Total Debt
$33M -0.0% ▼
Net Debt
-$3M +76.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$31M$31M$19M$41M$36M
Short-Term Investments$30M$8M$0$4M$4M
Cash & ST Investments$61M$39M$19M$45M$40M
Net Receivables$16M$23M$24M$24M$23M
Inventory$6M$7M$12M$15M$15M
Other Current Assets$2M$0$0$0$0
Total Current Assets$87M$70M$58M$87M$81M
Property, Plant & Equip.$30M$30M$27M$26M$28M
Goodwill & Intangibles$40M$83M$69M$69M$68M
Long-Term Investments$0$2M$0$0$0
Other Non-Current Assets$4M$4M$5M$2M$1M
Total Non-Current Assets$82M$124M$101M$99M$97M
Total Assets$169M$195M$158M$186M$179M
— Liabilities —
Accounts Payable$2M$2M$3M$3M$3M
Short-Term Debt$436K$10M$10M$0$0
Deferred Revenue$5M$5M$4M$4M$2M
Other Current Liabilities$5M$4M$5M$6M$14M
Total Current Liabilities$19M$30M$32M$24M$21M
Long-Term Debt$0$0$0$29M$30M
Other Non-Current Liab.$2M$8M$7M$5M$2M
Total Non-Current Liabilities$19M$25M$18M$42M$39M
Total Liabilities$38M$55M$50M$66M$60M
— Equity —
Common Stock$684K$695K$701K$708K$716K
Retained Earnings$112M$116M$89M$87M$76M
Accumulated OCI$3M$2M-$10M-$5M-$2M
Total Stockholders Equity$131M$140M$108M$120M$119M
Total Liabilities & Equity$169M$195M$158M$186M$179M
— Key Metrics —
Total Debt$4M$14M$15M$33M$33M
Net Debt-$30M-$17M-$4M-$12M-$3M
Total Investments$30M$10M$0$4M$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms